BACKGROUND A benchmarking survey was conducted by the pharmaceutical collaboration for transparent Medical Information (phactMI™) consortium, with the goal to capture insights from the 27 member companies and their medical information organizations. METHODS phactMI™ Benchmarking Committee delivered an electronic survey to 27 United States (US) member companies' Medical Information (MI) departments between December 12, 2017 and February 20, 2018. The survey consisted of approximately 300 questions, divided into 9 topics which included multiple choice and open-ended questions about the following categories: medical information support provided based on different product lifecycles, key metrics measured to assess department performance, and other key services provided by medical information groups. RESULTS The extent of MI product support varied across the lifecycle of a product. Most companies provided MI product support throughout the product lifecycle starting from investigational all the way through mature; however, the extent of activities varied. The top key performance indicators (KPIs) that were reported to senior leadership included response turnaround time (59%) and inquiry volume (48%). Among the 27 companies, 85% noted using customer satisfaction surveys administered via links within written response documents and 52% verbally via the company's call center. Other services with which MI groups noted most involvement included congress booth support (100%), insights/metric reporting (96%), and training the sales force on the MI function (74%). Additional services included payor support clinical pathway submissions (22%), presenting at advisory boards (22%), and competitive intelligence (26%). CONCLUSION The results of this survey provide pharmaceutical MI groups with opportunities to consider services or activities that could enhance the support these groups provide to their customers and business partners.

中文翻译：

---

Pharma Collaboration for Transparent Medical Information (phactMI™) 基准研究：产品支持活动、关键绩效指标和其他医疗信息服务的趋势、驱动因素和价值：来自对 27 个美国制药医疗信息部门的调查的见解

背景 透明医疗信息制药合作 (phactMI™) 联盟进行了一项基准调查，目的是从 27 家成员公司及其医疗信息组织中获取见解。方法 phactMI™ 基准委员会于 2017 年 12 月 12 日至 2018 年 2 月 20 日期间向 27 家美国 (US) 成员公司的医疗信息 (MI) 部门进行了电子调查。该调查包含大约 300 个问题，分为 9 个主题，其中包括关于以下类别的多项选择和开放式问题：基于不同产品生命周期提供的医疗信息支持、评估部门绩效的关键指标以及医疗信息集团提供的其他关键服务。结果 MI 产品支持的范围在产品的整个生命周期内各不相同。大多数公司在从研究到成熟的整个产品生命周期中都提供 MI 产品支持；然而，活动的范围各不相同。报告给高层领导的主要关键绩效指标 (KPI) 包括响应周转时间 (59%) 和查询量 (48%)。在这 27 家公司中，85% 的公司表示使用通过书面回复文件中的链接进行的客户满意度调查，52% 的公司通过公司的呼叫中心进行口头调查。MI 团体表示参与最多的其他服务包括会议展位支持 (100%)、洞察/指标报告 (96%) 以及对销售人员进行 MI 功能培训 (74%)。其他服务包括付款人支持临床路径提交 (22%)、在咨询委员会 (22%) 和竞争情报 (26%) 上发表演讲。结论 本次调查的结果为制药 MI 团体提供了考虑服务或活动的机会，这些服务或活动可以增强这些团体向其客户和业务合作伙伴提供的支持。